Clearline Capital LP Bridge Bio Pharma, Inc. Transaction History

Clearline Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $3.89 Million - $8.07 Million	-230,526 Reduced 87.68%	32,394 $854,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $28,174 - $38,181	-2,120 Reduced 0.8%	262,920 $4.52 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $195,024 - $504,560	-27,200 Reduced 9.31%	265,040 $4.39 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $76,418 - $130,613	11,338 Added 4.04%	292,240 $2.23 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $1.19 Million - $1.85 Million	-149,674 Reduced 34.76%	280,902 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $388,207 - $904,575	74,512 Added 20.93%	430,576 $3.91 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $2.61 Million - $6.11 Million	356,064 New	356,064 $3.61 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.